Abstract:Transforming growth factor-β (TGF-β) is the primary factor that drives fibrosis in most, if not all, forms of chronic kidney disease (CKD). However, direct targeting of TGF-β is unlikely to be therapeutically feasible due to the involvement of TGF-β in other systems, including the immune system. Hence, the aim of this study was to identify Sirtuin 2 (SIRT2) as an endogenous regulatory of TGF-β signaling and renal fibrosis. In current study, we demonstrated that SIRT2 was downregulated in the renal tubules of patients with CKD and DKD, as well as a mouse model of renal fibrosis. In kidneys that are obstructed, specific deletion of Sirt2 in renal tubule epithelial cells (TEC) were shown to substantially aggravate renal fibrosis, and renal tubule specific overexpression of Sirt2 was sufficient to ameliorate renal fibrosis. Additionally, we showed that SIRT2 overexpression and knockdown restrained and enhanced TGF-β-induced fibrotic gene expression, respectively, in TEC. Mechanistically, SIRT2 reduced the phosphorylation, nuclear localization, and protein levels of SMAD2, leading to inhibition of the TGF-β signaling pathway. Further studies found that SIRT2 was able to directly interact with and deacetylate SMAD2 on lysine 451 and promote its ubiquitination and degradation. The mutation of lysine 451 to arginine in SMAD2 blocks the regulatory effect of SIRT2. Notably, loss of SMAD specific E3 ubiquitin protein ligase 2 abolished the ubiquitination and degradation of SMAD2 induced by SIRT2 in SMAD2. This study provides initial indication of the anti-fibrotic role of SIRT2 in renal tubules, suggesting its therapeutic potential for renal fibrosis.Funding Information: This work was supported by grants from the National Natural Science Foundation of China (82000824 to SY, 82170842 to ZL, 82171556 to LK), the Natural Science Foundation of Shenzhen City, China to ZL (No. KCXFZ20201221173600001), the National Key Research and Development Program of China (2018YFC2001100). Declaration of Interests: The authors have declared that no conflict of interest exists.Ethics Approval Statement: This study was approved by the Institutional Review Board and Ethics Committee of the Shenzhen People’s Hospital (approval no. LL-KT-2018338). Written informed consent was obtained from all participants prior to their inclusion in the study.All Animal care and experimental protocols for in vivo studies conformed to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH; NIH publication no.:85–23, revised 1996) and were approved by the Ethics Committee of the Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital (Shenzhen, China).

Nuclear Translocation of SIRT4 Mediates Deacetylation of U2AF2 to Modulate Renal Fibrosis Through Alternative Splicing-mediated Upregulation of CCN2

MiR-155-5p Promotes Renal Interstitial Fibrosis in Obstructive Nephropathy Via Inhibiting SIRT1 Signaling Pathway

SIRT2 Alleviated Renal Fibrosis by Deacetylating Conserved Lysine 451 on SMAD2 in Renal Tubular Epithelial Cells

SIRT2 Alleviated Renal Fibrosis by Deacetylating SMAD2 and SMAD3 in Renal Tubular Epithelial Cells.

Inhibition of SIRT2 Alleviates Fibroblast Activation and Renal Tubulointerstitial Fibrosis Via MDM2

UCP1 alleviates renal interstitial fibrosis progression through oxidative stress pathway mediated by SIRT3 protein stability

#2394 Inhibition of ACSS2-mediated H3K9 Crotonylation Alleviates Kidney Fibrosis Via IL-1β-dependent Macrophage Activation and Tubular Cell Senescence

Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence

Phosphorylation by GSK-3β increases the stability of SIRT6 to alleviate TGF-β-induced fibrotic response in renal tubular cells

Deubiquitinating enzyme USP11 promotes renal tubular cell senescence and fibrosis via inhibiting the ubiquitin degradation of TGF-β receptor II

Inhibition of ACSS2-mediated H3K9 Crotonylation Alleviates Kidney Fibrosis Via IL-1β-dependent Macrophage Activation and Tubular Cell Senescence

MAD2B-mediated SnoN Downregulation is Implicated in Fibroblast Activation and Tubulointerstitial Fibrosis.

NSD2 modulates Drp1-mediated mitochondrial fission in chronic renal allograft interstitial fibrosis by methylating STAT1

TGFβ-incurred Epigenetic Aberrations of Mirna and DNA Methyltransferase Suppress Klotho and Potentiate Renal Fibrosis

Activation Of Sirtuin-1 Promotes Renal Fibroblast Activation And Aggravates Renal Fibrogenesis

The Deacetylase Sirtuin 6 Protects Against Kidney Fibrosis by Epigenetically Blocking Β-Catenin Target Gene Expression.

Loss of Proximal Tubular Sirtuin 6 Aggravates Unilateral Ureteral Obstruction-Induced Tubulointerstitial Inflammation and Fibrosis by Regulation of β-catenin Acetylation

Pharmacological Inhibition of S100A4 Attenuates Fibroblast Activation and Renal Fibrosis

TGF-β Mediates Renal Fibrosis Via the Smad3-Erbb4-IR Long Noncoding RNA Axis

#2671 Renal tubular epithelial FFAR4 improves cellular senescence to alleviate interstitial fibrosis in CKD

The SP1/SIRT1/ACLY signaling axis mediates fatty acid oxidation in renal ischemia-reperfusion-induced renal fibrosis